0006-5331 : Welireg 40 mg Oral Tablet, Film Coated
NDC: | 0006-5331 |
Labeler: | Merck Sharp & Dohme Corp. |
Product Type: | Human Prescription Drug |
Drug Name: | Welireg |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA215383 |
Rev. Date: |
NDC Package Codes:
- 0006-5331-01: 90 TABLET, FILM COATED IN 1 BOTTLE (0006‑5331‑01)
- 0006-5331-58: 1 BOTTLE IN 1 CARTON (0006‑5331‑58) / 90 TABLET, FILM COATED IN 1 BOTTLE
- 0006-5331-59: 1 BOTTLE IN 1 CARTON (0006‑5331‑59) / 90 TABLET, FILM COATED IN 1 BOTTLE
Active Ingredients:
- Belzutifan
Dosage Strength:
- 40 mg
Pharmaceutical Classes:
- Cytochrome P450 3A4 Inducers [MoA]
- Hypoxia-inducible Factor 2 alpha Inhibitors [MoA]
- Hypoxia-inducible Factor Inhibitor [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0006-5055Next: 0006-5363 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.